Isolation and structure of the remarkable human cancer cell growth inhibitors spongistatins 2 and 3 from an eastern Indian Ocean Spongia sp.

Journal of the Chemical Society, Chemical Communications

Volumn , Issue 14, 1993, Pages 1166-1168

  Pettit, George R ^a   Cichacz, Zbigniew A ^a   Gao, Feng ^a   Herald, Cherry L ^a   Boyd, Michael R ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MACROCYCLIC COMPOUND; SPONGISTATIN; SPONGISTATIN 1; SPONGISTATIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; INDIAN OCEAN; MOUSE; NONHUMAN; SPONGE (PORIFERA); TUMOR CELL LINE;

EID: 0027171060     PISSN: 00224936     EISSN: None     Source Type: Journal    
DOI: 10.1039/C39930001166     Document Type: Article

References (18)

1. For part 282 of the series Antineoplastic Agents, see B. Gabrielsen, T.P. Monath, J.W. Huggins, J.J. Kirsi, M. Hollingshead, W.M. Shannon and G.R. Pettit, in: Natural Products as Antiviral Agents, ed. C.K. Chu and H.G. Cutler, Plenum, New York, 1992, pp. 121-134.
2. G.R. Pettit, Z.A. Cichacz, F. Gao, C.L. Herald, M.R. Boyd, J.M. Schmidt and J.N.A. Hooper, J. Org. Chem., 1993, 58, 1302;
3. G.R. Pettit, R. Tan, F. Gao, M.D. Williams, D.L. Doubek, M.R. Boyd, J.M. Schmidt, J-C. Chapuis, E. Hamel, R. Bai, J.N.A. Hooper and J.P. Tackett, J. Org. Chem., 1993, 58, 2538;
4. G.R. Pettit, F. Gao, D.L. Doubek, M.R. Boyd, E. Hamel, J.M. Schmidt, L.P. Tackett and K. Riitzler, Gazz. Chim. Ital., in the press.
5. S. Grant, R. Traylor, K. Bhalla, C. McCrady and G.R. Pettit, Leukemia, 1992, 6, 432.
6. C.W. McCrady, J. Saniswalis, G.R. Pettit, C. Howe and S. Grant, Br. J. Haematol., 1991, 77, 5.
7. T.M. Tuttle, T.H. Inge, K.P. Bethke, C.W. McCrady, G.R. Pettit and H.D. Bear, Cancer Res., 1992, 52, 548
8. L.M. Schuchter, A.H. Esa, W.S. May, M.K. Laulis, G.R. Pettit and A.D. Hess, Cancer Res., 1991, 51, 682
9. R.L. Hornung, J.W. Pearson, M. Beckwith and S.L. Longo, Cancer Res., 1992, 52, 101;
10. G.R. Pettit, ‘The Bryostatins’ in: Progress in the Chemistry of Organic Natural Products, ed. W. Herz, G.W. Kirby, W. Steglich and Ch, Tamm, Springer-Verlag, New York, 1991, no. 57, pp. 153-195.
11. G.R. Pettit, C.L. Herald, M.R. Boyd, J.E. Leet, C. Dufresne, D.L. Doubek, J.M. Schmidt, R.L. Cerny, J.N.A. Hooper and K.C. Riitzler, J. Med. Chem., 1991, 34, 3339
12. R. Bai, K.D. Paull, C.L. Herald, L. Malspeis, G.R. Pettit and E. Hamel, J. Biol Chem., 1991, 266, 15882.
13. R. Sakai, K.L. Rinehart, Y. Guan and A.H.-J. Wang, Proc. Natl. Acad. Sci., 1992, 89, 11456.
14. S. Matsunaga, N. Fusetani and Y. Nakao, Tetrahedron, 1992, 48, 8369.
15. N. Fusetani, T. Sugawara and S. Matsunaga, J. Org. Chem., 1991, 56, 4971.
16. M.R. Boyd, ‘Status of the NCI preclinical antitumour drug discovery screen,’ in, Principles and Practices of Oncology Updates, ed. V.T. deVita, Jr., S. Hellman and S.A. Rosenberg, Lippincott, Philadelphia, 1989, vol. 10, no. 3, pp. 1-12.
17. M.R. Boyd, K.D. Paull and L.R. Rubinstein, ‘Data display and analysis strategies from the NCI disease-oriented in vitro antiturnout drug screen,’ in, Cytotoxic Anticancer Drug Models and Concepts for Drug Discovery and Development, ed. F.A. Valeriote, T. Corbett and L. Baker, Kluwer, Amsterdam, 1992, pp: 11-34.
18. M.R. Boyd, ‘The Future of New Drug Development’, in, Current Therapy in Oncology, ed, J.E. Niederhuber, Mosby, St. Louis, 1993, pp. 11-22.